SELENOS and metabolic dysfunction-associated steatotic liver disease: For example, one bioinformatic analysis compared gene expression levels of known selenoproteins and selenium-containing pathways between healthy individuals and MASLD patients from online repositories, suggesting that the liver with MASLD may have lower selenium levels than the healthy liver [99].